Myoblasts derived from normal hESCs and dystrophic hipscs efficiently fuse with existing muscle fibers following transplantation

Molecular Therapy

Volumn 20, Issue 11, 2012, Pages 2153-2167

  Goudenege, Sébastien ^a   Lebel, Carl ^a   Huot, Nicolas B ^a   Dufour, Christine ^a   Fujii, Isao ^b   Gekas, Jean ^a   Rousseau, Joël ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARDIOTOXIN; MYOD PROTEIN; SPECTRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; MYOBLAST; MYOD GENE; MYOTUBE; NONHUMAN; PLURIPOTENT STEM CELL; STEM CELL TRANSPLANTATION; TERATOMA;

ADENOVIRIDAE; MUS;

EID: 84869079595     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.188     Document Type: Article

References (50)

1. Thomson, JA, Itskovitz-Eldor, J, Shapiro, SS, Waknitz, MA, Swiergiel, JJ, Marshall, VS et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147. (Pubitemid 28516247)
2. Trounson, A (2006). The production and directed differentiation of human embryonic stem cells. Endocr Rev 27: 208-219.
3. Partridge, TA, Morgan, JE, Coulton, GR, Hoffman, EP and Kunkel, LM (1989). Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337: 176-179. (Pubitemid 19025378)
4. Skuk, D, Goulet, M, Roy, B, Piette, V, Cote, CH, Chapdelaine, P et al. (2007). First test of a "high-Density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord 17: 38-46. (Pubitemid 46188617)
5. Zheng, JK, Wang, Y, Karandikar, A, Wang, Q, Gai, H, Liu, AL et al. (2006). Skeletal myogenesis by human embryonic stem cells. Cell Res 16: 713-722. (Pubitemid 44258924)
6. Zhu, S, Wurdak, H, Wang, J, Lyssiotis, CA, Peters, EC, Cho, CY et al. (2009). A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 4: 416-426.
7. Ozasa, S, Kimura, S, Ito, K, Ueno, H, Ikezawa, M, Matsukura, M et al. (2007). Efficient conversion of ES cells into myogenic lineage using the gene-inducible system. Biochem Biophys Res Commun 357: 957-963. (Pubitemid 46693664)
8. Darabi, R, Baik, J, Clee, M, Kyba, M, Tupler, R and Perlingeiro, RC (2009). Engraftment of embryonic stem cell-Derived myogenic progenitors in a dominant model of muscular dystrophy. Exp Neurol 220: 212-216.
9. Darabi, R, Pan, W, Bosnakovski, D, Baik, J, Kyba, M and Perlingeiro, RC (2011). Functional myogenic engraftment from mouse iPS cells. Stem Cell Rev 7: 948-957.
10. Chang, H, Yoshimoto, M, Umeda, K, Iwasa, T, Mizuno, Y, Fukada, S et al. (2009). Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J 23: 1907-1919.
11. Barberi, T, Bradbury, M, Dincer, Z, Panagiotakos, G, Socci, ND and Studer, L (2007). Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13: 642-648. (Pubitemid 46828477)
12. Berkes, CA and Tapscott, SJ (2005). MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 16: 585-595. (Pubitemid 41247882)
13. Weintraub, H, Tapscott, SJ, Davis, RL, Thayer, MJ, Adam, MA, Lassar, AB et al. (1989). Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 86: 5434-5438. (Pubitemid 19185563)
14. Goudenege, S, Pisani, DF, Wdziekonski, B, Di Santo, JP, Bagnis, C, Dani, C et al. (2009). Enhancement of myogenic and muscle repair capacities of human adiposederived stem cells with forced expression of MyoD. Mol Ther 17: 1064-1072.
15. Shani, M, Faerman, A, Emerson, CP, Pearson-White, S, Dekel, I and Magal, Y (1992). The consequences of a constitutive expression of MyoD1 in ES cells and mouse embryos. Symp Soc Exp Biol 46: 19-36.
16. Dekel, I, Magal, Y, Pearson-White, S, Emerson, CP and Shani, M (1992). Conditional conversion of ES cells to skeletal muscle by an exogenous MyoD1 gene. New Biol 4: 217-224.
17. Brokhman, I, Pomp, O, Fishman, L, Tennenbaum, T, Amit, M, Itzkovitz-Eldor, J et al. (2009). Genetic modification of human embryonic stem cells with adenoviral vectors: Differences of infectability between lines and correlation of infectability with expression of the coxsackie and adenovirus receptor. Stem Cells Dev 18: 447-456.
18. Skuk, D, Goulet, M, Roy, B, Chapdelaine, P, Bouchard, JP, Roy, R et al. (2006). Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-Density injections of normal myogenic cells. J Neuropathol Exp Neurol 65: 371-386. (Pubitemid 44264834)
19. Minguillon, C, Del Buono, J and Logan, MP (2005). Tbx5 and Tbx4 are not sufficient to determine limb-specific morphologies but have common roles in initiating limb outgrowth. Dev Cell 8: 75-84. (Pubitemid 40058007)
20. Shih, HP, Gross, MK and Kioussi, C (2008). Muscle development: Forming the head and trunk muscles. Acta Histochem 110: 97-108. (Pubitemid 351318009)
21. Kuang, S and Rudnicki, MA (2008). The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14: 82-91.
22. Skuk, D (2004). Myoblast transplantation for inherited myopathies: A clinical approach. Expert Opin Biol Ther 4: 1871-1885. (Pubitemid 39627139)
23. Hoffman, EP, Brown, RH Jr and Kunkel, LM (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
24. Skuk, D, Paradis, M, Goulet, M, Chapdelaine, P, Rothstein, DM and Tremblay, JP (2010). Intramuscular transplantation of human postnatal myoblasts generates functional donor-Derived satellite cells. Mol Ther 18: 1689-1697.
25. Skuk, D, Roy, B, Goulet, M, Chapdelaine, P, Bouchard, JP, Roy, R et al. (2004). Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 9: 475-482. (Pubitemid 38404538)
26. Gang, EJ, Darabi, R, Bosnakovski, D, Xu, Z, Kamm, KE, Kyba, M et al. (2009). Engraftment of mesenchymal stem cells into dystrophin-Deficient mice is not accompanied by functional recovery. Exp Cell Res 315: 2624-2636.
27. Eiges, R (2006). Genetic manipulation of human embryonic stem cells by transfection. Methods Mol Biol 331: 221-239.
28. Itskovitz-Eldor, J, Schuldiner, M, Karsenti, D, Eden, A, Yanuka, O, Amit, M et al. (2000). Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6: 88-95.
29. Rudnicki, MA, Braun, T, Hinuma, S and Jaenisch, R (1992). Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71: 383-390.
30. Kablar, B, Krastel, K, Ying, C, Asakura, A, Tapscott, SJ and Rudnicki, MA (1997). MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development 124: 4729-4738. (Pubitemid 28014376)
31. Rudnicki, MA, Schnegelsberg, PN, Stead, RH, Braun, T, Arnold, HH and Jaenisch, R (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359. (Pubitemid 24021909)
32. Giordani, J, Bajard, L, Demignon, J, Daubas, P, Buckingham, M and Maire, P (2007). Six proteins regulate the activation of Myf5 expression in embryonic mouse limbs. Proc Natl Acad Sci USA 104: 11310-11315.
33. Kitzmann, M, Carnac, G, Vandromme, M, Primig, M, Lamb, NJ and Fernandez, A (1998). The muscle regulatory factors MyoD and myf-5 undergo distinct cell cyclespecific expression in muscle cells. J Cell Biol 142: 1447-1459. (Pubitemid 28452595)
34. Tapscott, SJ and Weintraub, H (1991). MyoD and the regulation of myogenesis by helix-loop-helix proteins. J Clin Invest 87: 1133-1138.
35. Huard, C, Moisset, PA, Dicaire, A, Merly, F, Tardif, F, Asselin, I et al. (1998). Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem Biophys Res Commun 248: 648-654. (Pubitemid 28404475)
36. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
37. Skuk, D, Goulet, M, Roy, B and Tremblay, JP (2002). Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: Toward defining strategies applicable to humans. Exp Neurol 175: 112-126. (Pubitemid 34507914)
38. Patterson, M, Chan, DN, Ha, I, Case, D, Cui, Y, Van Handel, B et al. (2012). Defining the nature of human pluripotent stem cell progeny. Cell Res 22: 178-193.
39. Zhao, T, Zhang, ZN, Rong, Z and Xu, Y (2011). Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.
40. Chin, MH, Mason, MJ, Xie, W, Volinia, S, Singer, M, Peterson, C et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123.
41. Gore, A, Li, Z, Fung, HL, Young, JE, Agarwal, S, Antosiewicz-Bourget, J et al. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
42. Ninagawa, N, Murakami, R, Isobe, E, Tanaka, Y, Nakagawa, H and Torihashi, S (2011). Mesenchymal stem cells originating from ES cells show high telomerase activity and therapeutic benefits. Differentiation 82: 153-164.
43. Halevy, O, Novitch, BG, Spicer, DB, Skapek, SX, Rhee, J, Hannon, GJ et al. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
44. Wagstaff, KM and Jans, DA (2006). Protein transduction: Cell penetrating peptides and their therapeutic applications. Curr Med Chem 13: 1371-1387.
45. Ludwig, TE, Bergendahl, V, Levenstein, ME, Yu, J, Probasco, MD and Thomson, JA (2006). Feeder-independent culture of human embryonic stem cells. Nat Methods 3: 637-646. (Pubitemid 44123431)
46. Fujii, I, Matsukura, M, Ikezawa, M, Suzuki, S, Shimada, T and Miike, T (2006). Adenoviral mediated MyoD gene transfer into fibroblasts: Myogenic disease diagnosis. Brain Dev 28: 420-425. (Pubitemid 43949332)
47. Park, IH, Arora, N, Huo, H, Maherali, N, Ahfeldt, T, Shimamura, A et al. (2008). Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
48. Huard, J, Tremblay, G, Verreault, S, Labrecque, C and Tremblay, JP (1993). Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice. Cell Transplant 2: 113-118. (Pubitemid 23134487)
49. Rando, TA and Blau, HM (1994). Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125: 1275-1287. (Pubitemid 24189532)
50. Benabdallah, BF, Bouchentouf, M, Rousseau, J, Bigey, P, Michaud, A, Chapdelaine, P et al. (2008). Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transplant 17: 337-350. (Pubitemid 351717336)